april
first
case
acut
respiratori
infect
caus
novel
triplereassort
influenza
viru
occur
mexico
unit
state
rapid
spread
infect
contin
led
world
health
organ
declar
june
pandem
influenza
way
rais
major
intern
concern
risk
high
morbid
lethal
potenti
sever
socioeconom
impact
actual
potenti
impact
first
thirdmillenium
influenza
pandem
revisit
downward
morbid
casefat
rate
less
sever
initi
anticip
ill
surveil
data
allow
accur
estim
true
influenza
infect
rate
substanti
proport
infect
asymptomat
mild
serolog
survey
overcom
limit
must
take
account
signific
proport
popul
exhibit
crossprotect
antibodi
titer
circul
socal
baselin
immun
subtract
seropreval
observ
pandem
wave
determin
seroincid
serosurvey
howev
except
studi
serosurvey
use
serial
measur
person
allow
better
understand
antibodi
kinet
dynam
infect
within
individu
commun
reunion
island
inhabit
french
oversea
depart
locat
southwestern
indian
ocean
km
east
madagascar
km
southwest
mauritiu
first
import
case
identifi
juli
week
travel
return
australia
first
case
indic
commun
transmiss
detect
juli
week
becam
predomin
circul
influenza
viru
within
four
week
first
detect
activ
peak
week
august
end
week
contrari
initi
fear
health
care
system
overwhelm
morbid
mortal
rate
lower
predict
order
assess
commun
level
actual
magnitud
pandem
extent
herd
immun
acquir
passag
epidem
wave
prospect
popul
serosurvey
conduct
reunion
island
passag
epidem
wave
austral
winter
season
preval
infect
assess
weekli
basi
seroconvers
rate
measur
use
pair
sera
copanflurun
part
copanflu
intern
project
consortium
french
nation
institut
health
medic
research
inserm
institut
research
develop
ird
fondat
promot
school
advanc
studi
public
health
ehesp
enabl
rapid
implement
studi
anticip
immin
spread
pandem
wave
use
preexist
sampl
household
establish
octob
investig
chikungunya
outbreak
serochik
updat
may
throughout
followup
telephon
survey
telechik
basi
household
took
special
attent
select
household
repres
wide
rang
geograph
locat
order
minim
repartit
bia
inclus
phase
start
juli
week
continu
week
throughout
epidem
wave
beyond
first
serum
sampl
sampl
obtain
household
member
activ
telephon
inquiri
conduct
twice
week
record
symptom
compat
influenzalik
ill
ili
occur
household
report
ili
fever
associ
respiratori
system
symptom
led
three
consecut
visit
nurs
incid
casedwel
day
postreport
record
symptom
collect
nasal
swab
famili
member
qrtpcr
detect
week
activ
inquiri
discontinu
second
postepidem
serum
sampl
sampl
obtain
week
determin
seroconvers
rate
sera
aliquot
store
protocol
conduct
accord
declar
helsinki
french
law
biomed
research
id
rcb
afssap
approv
local
ethic
committe
de
protect
de
personn
bordeaux
univers
everi
elig
person
particip
ask
give
written
inform
consent
viral
rna
extract
nasal
swab
eluat
use
qiaamp
viral
rna
kit
qiagen
process
detect
taqman
qrtpcr
target
heamagglutinin
ha
gene
superscript
iii
platinum
onestep
qrtpcr
system
invitrogen
accord
recommend
pasteur
institut
van
der
werf
enouf
v
confirm
infect
defin
posit
qrtpcr
detect
ha
gene
least
one
nasal
swab
standard
hemagglutin
inhibit
techniqu
adapt
detect
quantifi
antibodi
antigen
prepar
dilut
noninactiv
cell
cultur
supernat
produc
pdm
strain
strain
isol
young
patient
return
mexico
earli
may
briefli
viru
propag
onto
mdck
cell
standard
condit
last
passag
use
antigen
prepar
perform
absenc
trypsin
htfb
supernat
collect
day
seven
pi
clarifi
centrifug
g
min
room
temperatur
aliquot
conserv
hemagglutin
titer
non
inactiv
viral
antigen
immedi
determin
hia
format
describ
dilut
provid
hemagglutin
unit
volum
use
subsequ
hia
sera
heatinactiv
min
prior
use
sequenti
twofold
dilut
pb
volum
perform
distribut
vbottom
well
micropl
human
red
blood
cell
rbc
use
hemagglutin
experi
detect
quantif
antibodi
perform
follow
viru
suspens
ad
serum
dilut
incub
hour
room
temperatur
well
fill
rbc
suspens
pb
vv
follow
anoth
min
incub
room
temperatur
hia
titer
determin
last
dilut
provid
clear
inhibit
hemagglutin
experi
perform
presenc
neg
posit
control
latter
includ
sera
antibodi
titer
result
report
studi
base
serolog
analysi
pair
sera
sake
analysi
four
success
phase
identifi
throughout
pandem
wave
phase
week
correspond
earli
epidem
time
phase
b
epidem
unfold
phase
c
immedi
postepidem
stage
phase
late
postepidem
stage
seroposit
defin
hia
titer
baselineproxi
seropreval
rate
estim
serum
sampl
collect
phase
cumul
incid
rate
infect
measur
rais
raw
seropreval
rate
given
time
epidem
phase
agespecif
baselineproxi
seropreval
rate
seroconvers
defin
shift
seroneg
inclus
sampl
hia
seroposit
followup
sampl
hia
sera
test
seroposit
inclus
fourfold
increas
hia
titer
sampl
sampl
pair
sera
also
calcul
proport
sera
test
seroposit
sampl
hia
titer
decreas
fourfold
pass
cutoff
valu
sampl
consid
proport
seroneg
rate
sampl
size
calcul
identifi
risk
factor
prospect
cohort
studi
consid
averag
three
individu
per
household
intrahousehold
correl
power
greater
could
obtain
sampl
size
compris
individu
assum
exposur
level
rang
rel
risk
greater
subject
studi
allow
absolut
precis
around
estim
valu
seroconvers
rate
data
entri
use
epidata
version
epidata
associ
odens
denmark
sa
version
sa
inc
cari
nc
usa
use
statist
analysi
characterist
studi
cohort
compar
popul
reunion
island
test
fisher
exact
test
non
applic
use
analys
differ
age
sex
geograph
locat
cumul
incid
rate
infect
ie
seroincid
seroconvers
rate
standard
accord
age
structur
commun
french
nation
institut
statist
econom
studi
inse
sourc
baselineproxi
seropreval
cumul
incid
rate
infect
well
seroconvers
seroneg
rate
express
percentag
cumul
revers
distribut
curv
use
show
distribut
antibodi
titer
test
p
valu
consid
signific
estim
confid
interv
ci
proport
use
cluster
bootstrap
techniqu
resampl
bootstrap
use
anova
model
compar
mean
cumul
incid
proport
pandem
phase
within
age
group
use
altern
logist
regress
model
alr
exchang
log
odd
ratio
test
intrahousehold
correlationadjust
associ
factor
seroconvers
outcom
data
analys
respect
subject
age
initi
four
age
group
consid
children
adolesc
yr
young
adult
yr
middleag
adult
yr
elderli
adult
yr
cumul
incid
infect
second
third
group
close
group
merg
one
adult
group
yr
therefor
refer
studi
three
age
group
children
adolesc
yr
adult
yr
elderli
yr
total
individu
household
enrol
week
copanflurun
cohort
allow
collect
sera
inclus
sampl
period
household
household
contain
individu
individu
report
least
one
case
ili
sixti
subject
among
individu
belong
household
qrtpcr
posit
document
infect
posit
qrtpcr
could
detect
week
ili
report
week
end
epidem
wave
second
follow
serum
sampl
sampl
obtain
subject
least
five
week
end
epidem
wave
week
allow
constitut
serobank
pairedsera
profil
cohort
major
outcom
display
figur
detail
inclus
serum
sampl
time
respect
circul
island
provid
figur
sociodemograph
spacetim
characterist
cohort
detail
tabl
compar
commun
reunion
island
sampl
individu
pairedsera
avail
older
yr
vs
yr
vs
compos
slight
excess
femal
vs
imbal
due
deficit
subject
age
year
reflect
men
work
fact
parent
declin
second
serum
children
younger
five
baselineproxi
hia
titer
measur
sampl
tabl
obtain
subject
household
recruit
begin
investig
week
phase
figur
epidem
activ
cohort
still
low
age
distribut
group
similar
whole
cohort
data
shown
overal
baselineproxi
seropreval
rate
hia
age
ci
howev
major
posit
sera
low
antibodi
titer
cut
valu
confirm
ie
proport
sera
hia
titer
young
middleag
older
age
group
respect
result
indic
preepidem
baselin
antibodi
cross
reactiv
stronger
elderli
yr
weaker
children
adolesc
yr
adult
yr
highli
signific
differ
age
group
p
revers
cumul
distribut
curv
hia
titer
display
age
group
whole
cohort
figur
proport
seroposit
sera
hi
steadili
increas
epidem
unfold
phase
b
immedi
post
epidem
period
phase
c
reach
maximum
level
declin
late
post
epidem
period
phase
declin
signific
enough
return
revers
cumul
distribut
curv
baselin
level
elderli
cumul
incid
rate
obtain
subtract
agespecif
baselineproxi
seropreval
raw
seropreval
phase
epidem
shown
tabl
note
cumul
incid
rate
infect
repres
group
age
standard
accord
age
structur
commun
cumul
incid
rate
much
higher
children
adolesc
yr
indic
activ
transmiss
infect
within
age
group
mention
earlier
cumul
incid
rate
peak
phase
c
declin
indic
labil
humor
immun
respons
agerel
differ
observ
incid
rate
highli
statist
signific
p
estim
appropri
declin
antibodi
titer
occur
peak
humor
respons
consid
pairedsera
group
subject
first
serum
sampl
sampl
obtain
epidem
wave
phase
c
correspond
second
sampl
collect
end
survey
phase
seroneg
rate
age
group
children
adolesc
yr
adult
yr
elderli
yr
differ
seroneg
rate
accord
age
statist
weakli
signific
p
consid
individu
pair
sera
avail
measur
seroconvers
rate
accord
age
time
first
serum
sampl
collect
phase
b
c
criteria
seroconvers
defin
method
section
shown
tabl
sharp
declin
seroconvers
rate
across
age
group
depend
whether
particip
enrol
phase
phase
b
phase
c
p
interpret
data
one
rememb
antibodi
seroprotect
level
hia
serum
sampl
collect
per
epidem
phase
b
earli
post
epidem
phase
c
could
repres
either
base
line
cross
reactiv
antibodi
rise
specif
antibodi
due
recent
ongo
infect
ambigu
could
lead
underestim
seroconvers
rate
subject
enrol
phase
b
c
order
solv
ambigu
specif
consid
group
subject
cross
reactiv
antibodi
detect
time
phase
seroconvers
rate
group
indic
exposur
individu
whole
epidem
wave
highest
p
children
adolesc
yr
still
significantli
high
adult
p
test
particular
group
impact
baselin
preepidem
cross
reactiv
antibodi
rate
seroconvers
tabl
subject
hia
titer
superior
evid
seroconvers
seroconvers
rate
individu
hia
titer
equal
link
age
import
children
adolesc
yr
highest
seroconvers
rate
regist
subject
hia
titer
inferior
particularli
year
reach
henc
risk
seroconvers
decreas
preepidem
hia
titer
high
control
age
p
figur
multivari
adjust
odd
ratio
seroconvers
ci
p
per
twofold
increas
baselin
titer
ci
p
per
household
member
seroconvert
ci
p
age
year
vs
age
year
ci
p
age
year
vs
age
year
observ
predict
seroconvers
rate
accord
age
baselin
hia
titer
display
figur
final
consid
subject
infect
pandem
viru
cours
studi
verifi
posit
qrtpcr
nasal
swab
pair
sera
avail
initi
hia
antibodi
titer
group
one
one
subject
respect
end
survey
individu
test
seroposit
hia
titer
hia
titer
thirtyfour
subject
seroconvert
copanflurun
cohort
set
conduct
prospect
populationbas
studi
investig
herd
immun
induc
pandem
influenza
viru
identifi
risk
factor
infect
pair
sera
collect
entir
commun
work
publish
date
use
either
extens
crosssect
serosurvey
pre
postepidem
independ
serum
sampl
baselin
immun
assess
store
frozen
sampl
non
repres
adult
cohort
militari
health
care
worker
longstay
patient
antibodi
titer
measur
hia
use
cutoff
valu
set
classic
recommend
hia
titer
consid
protect
ie
confer
protect
viral
challeng
assay
introduc
chang
experiment
protocol
compar
classic
one
use
noninactiv
viral
antigen
ie
nativ
viru
nondenatur
epitop
probabl
allow
detect
antibodi
epitop
hemagglutinin
detect
classic
hia
test
induc
slight
differ
sensit
detect
crossreact
antibodi
modifi
kinet
ab
epidemiolog
evolut
seropreval
jeopard
global
compar
serolog
result
confirm
fact
hi
assay
detect
seroprotect
antibodi
titer
gave
evid
seroconvers
qrtpcr
confirm
influenza
figur
close
report
literatur
consid
titer
sera
collect
individu
enrol
week
cross
reactiv
antibodi
de
novo
antibodi
trigger
pandem
viru
henc
use
proxi
baselin
pre
epidem
immun
sever
argument
support
assumpt
first
case
indic
autochthon
transmiss
reunion
island
report
epidemiolog
surveil
depart
la
juli
week
ie
day
inclus
start
studi
cohort
ii
day
requir
develop
antibodi
respons
viral
infect
iii
week
epidem
activ
due
pandem
viru
low
studi
cohort
becam
signific
week
henc
week
household
recruit
household
report
ili
case
nasal
swab
collect
individu
test
qrtpcr
neg
pandem
viru
wherea
one
evid
coronaviru
rhinoviru
use
multiplex
rtpcr
respiratori
virus
h
pascali
manuscript
prepar
contrast
week
individu
belong
household
report
ili
among
individu
document
infect
pandem
viru
studi
show
substanti
proport
reunion
island
popul
preexist
immun
pandem
influenza
viru
highest
baselineproxi
seropreval
rate
observ
among
adult
age
year
studi
contin
also
report
high
preepidem
seroposit
rate
among
elderli
though
larg
variat
exist
countri
cross
reactiv
antibodi
interpret
residu
signatur
remot
exposur
individu
virus
circul
baselin
seroposit
rate
report
children
younger
adult
ie
notabl
higher
report
part
world
howev
one
note
baselin
antibodi
low
titer
level
hia
threshold
ie
sever
factor
could
contribut
compar
high
baselin
rate
found
studi
may
reflect
fact
hi
test
use
studi
margin
sensit
classic
one
ii
individu
may
alreadi
infect
viru
week
may
trigger
antibodi
respons
viru
hypothesi
seem
unlik
view
argument
present
similar
high
proport
sera
titer
hia
among
sera
adult
patient
sent
diagnost
purpos
region
hospit
microbiolog
laboratori
first
half
ie
pandem
data
shown
howev
formal
exclud
hypothesi
view
recent
report
studi
taiwan
show
evid
subclin
commun
transmiss
prove
seroconvers
sever
week
report
first
document
case
island
similar
conclus
also
drawn
australia
iii
serolog
test
might
detect
crossreact
antibodi
trigger
recent
vaccin
trival
season
influenza
vaccin
report
howev
season
influenza
vaccin
rather
limit
use
reunion
island
especi
children
young
adult
iv
final
high
baselin
titer
may
reflect
infecti
histori
individu
season
influenza
virus
cross
antigen
viru
recent
suggest
season
infect
serosurvey
indic
larg
fraction
reunion
island
popul
infect
pandem
viru
younger
peopl
paid
main
tribut
epidem
almost
two
third
show
evid
seroconvers
confirm
earlier
clinic
report
island
accumul
report
countri
suggest
school
children
like
play
central
role
epidem
diffus
pandem
viru
lower
infect
rate
found
adult
lowest
rate
record
elderli
base
clinic
case
report
epidemiolog
surveil
servic
estim
person
reunion
island
consult
physician
infect
viru
week
epidem
give
cumul
attack
rate
take
account
consult
physician
number
symptomat
infect
person
estim
attack
rate
fact
attack
rate
infect
serosurvey
peak
antibodi
respons
ie
week
figur
least
time
higher
rate
infect
base
clinic
case
wide
gap
two
estim
indic
larg
fraction
almost
two
third
got
infect
viru
escap
medic
detect
probabl
develop
mild
diseas
asymptomat
infect
indic
benign
natur
viru
least
commun
level
england
baguelin
et
al
estim
cumul
incid
rate
infect
pandem
viru
children
time
higher
estim
clinic
surveil
studi
other
indic
preexist
cross
reactiv
antibodi
titer
prevent
seroconvers
respons
pandem
viru
level
preexist
cross
reactiv
immun
like
confer
true
protect
infect
two
third
one
third
document
infect
qrtpcr
posit
seri
occur
individu
baselin
hia
titer
respect
less
document
infect
occur
individu
base
line
titer
protect
effect
older
adult
also
younger
person
indic
protect
confer
baselin
cross
reactiv
antibodi
trigger
close
virus
circul
elderli
also
antibodi
like
result
recent
exposur
season
influenza
epidem
shown
younger
person
observ
seroconvers
rate
depend
age
adjust
baselin
titer
protect
role
increas
age
might
explain
stronger
crossimmun
adult
elderli
higher
exposur
young
subject
viru
epidem
due
social
contact
mix
pattern
may
also
indic
immun
mechan
cross
reactiv
antibodi
detect
hia
ie
immun
neuraminidas
conserv
cell
epitop
might
develop
throughout
life
provid
addit
protect
infect
sever
diseas
especi
elderli
interestingli
evid
seen
declin
antibodi
titer
occur
soon
passag
epidem
wave
pair
sera
declin
signific
enough
bring
within
week
almost
sera
test
posit
ie
hi
titer
immedi
post
epidem
phase
level
cutoff
valu
second
serum
sampl
decay
account
observ
older
adult
yr
studi
cohort
appar
almost
complet
spare
epidem
one
consid
cumul
incid
rate
deriv
iha
titrat
sampl
week
fact
cumul
incid
rate
older
adult
measur
epidem
peak
ie
week
similar
result
earli
antibodi
decay
recent
report
gener
data
show
serosurvey
conduct
month
passag
epidem
like
underestim
real
extent
infect
compar
antibodi
titrat
perform
earlier
humor
respons
highest
level
whether
declin
antibodi
titer
function
immunolog
consequ
individu
within
commun
warrant
investig
howev
one
note
second
epidem
wave
reunion
island
subsequ
austral
winter
season
influenza
winter
level
higher
usual
passag
season
flu
though
almost
two
third
document
case
also
due
addit
mani
fewer
pandem
viru
isol
note
ongo
austral
winter
strongli
suggest
first
epidem
wave
confer
solid
herd
immun
commun
level
studi
limit
fact
epidem
progress
coincid
implement
prospect
studi
abl
collect
strictli
speak
preepidem
sera
cohort
member
therefor
use
proxi
base
line
seropreval
data
individu
recruit
begin
investig
epidem
activ
cohort
low
may
overestim
base
line
immun
subclin
commun
transmiss
occur
first
case
influenza
report
antibodi
pandem
viru
detect
hia
test
good
specif
rather
low
sensit
henc
threshold
may
underestim
number
infect
individu
howev
rate
seroconvers
serolog
gold
standard
test
base
pair
sera
like
gave
accur
pictur
pandem
commun
level
reunion
island
